angioblast


Also found in: Encyclopedia, Wikipedia.

angioblast

 [an´je-o-blast″]
1. the earliest formative tissue from which blood cells and blood vessels arise.
2. an individual vessel-forming cell. adj., adj angioblast´ic.

an·gi·o·blast

(an'jē-ō-blast),
1. A cell taking part in blood vessel formation. Synonym(s): vasoformative cell
2. Primordial mesenchymal tissue from which embryonic blood cells and vascular endothelium are differentiated. Synonym(s): angioderm
[angio- + G. blastos, germ]

angioblast

(ăn′jē-ə-blăst′)
n.
1. A cell taking part in blood vessel formation.
2. The primordial mesenchymal tissue from which embryonic blood cells and vascular endothelium are differentiated.

angioblast

A primitive mesenchymal tissue that develops into bone marrow and blood vessels. Angioblasts appear at the primitive streak stage, in the body stalk, and in the yolk sac within blood islands.

an·gi·o·blast

(an'jē-ō-blast)
1. A cell taking part in blood vessel formation.
Synonym(s): vasoformative cell.
2. Primordial mesenchymal tissue from which embryonic blood cells and vascular endothelium are differentiated.
[angio- + G. blastos, germ]
References in periodicals archive ?
RT-PCR analyses showed both mesodermal and angioblast markers; that is, Brachyury, Flk1, Flt1, Tie1, Tie2, VE-cad, PU.1, SCL/Tal1, and Lmo2, were expressed in [Flk1.sup.+] cells purified employing MACS (Figure 1(d)).
In addition, Mesoblast plans to offer further 94.6 million shares to Angioblast security holders, it said.
Angioblast and Mesoblast are conducting a Pilot Clinical Trial in Australia focused on the treatment of up to 10 patients suffering from severe coronary artery disease and heart muscle damage.
Therefore, expression of TIE-2 substantiates the presence of an intermediate stage that gives rise to both haemogenic endothelium (HE) and angioblasts [30].
Mesoblast also advises that it has finalized the acquisition of its United States associate company, Angioblast Systems Inc.
- We are finalizing a major strategic acquisition of our United States associate company, Angioblast Systems, that will enable Mesoblast shareholders to enjoy all the commercial benefits of the unique technology platform
Melbourne, Australia, Nov 19, 2010 - (ABN Newswire) - Australian regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today announced that the required period for any antitrust objection under the United States Hart-Scott-Rodino(HSR) anti-trust improvement Act 1976 in respect of its acquisition of Angioblast Systems Inc.
Melbourne, Australia, Nov 8, 2010 - (ABN Newswire) - Regenerative medicine company, Mesoblast Limited (ASX:MSB) (USOTC:MBLTY), today announced that its United States associate company, Angioblast Systems, has been awarded $1.2 million in grants under the United States Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Melbourne, Australia, Sep 22, 2010 - (ABN Newswire) - Shareholders of Australian regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today overwhelmingly approved the acquisition of its United States associate company, Angioblast Systems Inc.
[CD.sup.133.+] cells can differentiate into both myocytes and endothelial cells, but [CD.sup.34.+] cells may be differentiate to give only endothelial cells via angioblast maturation.
At the same time, our associate company in the United States, Angioblast Systems Inc., has also had remarkable achievements in its objectives to commercialise the shared stem cell technology platform for a range of non-orthopaedic applications, including heart diseases, oncology, diabetes, and eye diseases.
described the emergence of a multipotent MSC precursor, the mesenchymo angioblast, from hESC derived CD34+ cells in a stepwise differentiation system [96].